The preovulatory release of luteinizing hormone (LH) in the domestic hen occurs after the initiation of a preovulatory surge of testosterone. The objective of this study was to determine whether this testosterone surge has functional significance in the endocrine control of ovulation. Groups of laying hens (nZ10-22) were treated with the androgen receptor antagonist, flutamide, at 8 h intervals for 24 h at doses of 0, 31.25, 62.5, 125 and 250 mg. All doses reduced egg laying (P!0.001), with the highest dose being the most effective. In a second study, laying hens (nZ9) were treated with 250 mg flutamide at 8 h intervals for 24 h with a control group being given placebo (nZ10). Blood samples were taken for hormone measurements at 2 h intervals for 18 h starting 4 h before the onset of darkness. The percentage of hens laying per day did not differ between groups before treatment (control, 88% vs flutamide, 86%). Ovulation was blocked in all hens treated with flutamide within 2 days while the control hens continued to lay at the pretreatment rate (80%). Preovulatory surges of plasma testosterone, progesterone, oestradiol and LH were observed in control hens but with the exception of testosterone, flutamide treatment blocked the progesterone, oestradiol and LH surges. LH concentrations declined progressively with time in the flutamide-treated hens. It is concluded that inhibition of testosterone action blocks egg laying and the preovulatory surges of progesterone, luteinizing hormone and oestradiol demonstrating a key role for the preovulatory release of testosterone in the endocrine control of ovulation in the domestic hen.
Introduction
In the domestic hen, an increase in plasma progesterone, originating from the mature and maturing preovulatory ovarian follicles induces a preovulatory release of luteinizing hormone (LH) (Wilson & Sharp 1975a , Etches & Cunningham 1976 , Wilson & Cunningham 1984 , Etches 1996 , by stimulating the release of gonadotrophin-releasing hormone (Fraser & Sharp 1978) . The increase in plasma progesterone and LH 3-6 h before ovulation is preceded by increased plasma testosterone and plasma oestradiol (Johnson & van Tienhoven 1980a , Etches & Cheng 1981 . Oestradiol does not participate directly in the positive feedback control of LH release (Furr & Smith 1975 , Wilson & Sharp 1976a ), but it is necessary to prime the hypothalamus to allow the positive feedback action of progesterone (Wilson & Sharp 1976b) . A role for the preovulatory release of testosterone in the ovulatory process is suggested by the finding that injection of testosterone in laying hens with mature preovulatory follicles induces ovulation (Fraps 1955 , Croze & Etches 1980 ) and a preovulatory-like release of LH (Wilson & Sharp 1976a) , while blockage of testosterone action by passive immunization (Furr & Smith 1975 , Rangel et al. 2005 or active immunization against testosterone (Rangel et al. 2005 ) blocks ovulation. Further, active immunization against testosterone induces atresia of preovulatory yellow yolky follicles, but does not prevent their development (Rangel et al. 2005) , while chronic treatment with the steroidal androgen receptor antagonist, cyproterone acetate, blocks ovulation and induces ovarian regression (Luck 1982) . Fraps (1955) found that, while injection of hens with mature preovulatory follicles with progesterone induced ovulation within 8 h, injection with testosterone induced ovulation after more than 9 h, and suggested that testosterone must first be converted to an "active substance" before ovulation could be induced. Croze and Etches (1980) found that ovulation could only be induced using doses of testosterone which produced unphysiologically high plasma concentrations, and suggested that the preovulatory release of testosterone has "a preparatory or priming action on the hypothalamopituitary-ovarian system which facilitates the preovulatory release of LH". Our hypothesis is that blocking the action of the preovulatory surge of testosterone, with its specific antagonist flutamide (a non-steroidal androgen receptor antagonist; Mainwaring et al. 1987) , will halt the predicted oviposition and the preovulatory surges of plasma testosterone, progesterone, oestradiol and LH in the laying hen. This study will increase our understanding of the functional significance of the preovulatory surge of testosterone. In the chicken, flutamide is known to be biologically active since administration in ovo changes sexual dimorphism in body weight and muscle characteristics of embryos (Henry & Burke 1999 ) and posthatching chicks (Burke 1996) .
Materials and Methods

Experimental animals
Eighteen-month-old laying hens (Gallus domesticus, HiLine, supplied by Hi-Line México) beginning the second laying year were housed in individual cages with water and food ad libitum, under a 16 h light:8 h dark schedule (light on at 04 00 h) and ovipositions were recorded daily.
Experimental design
Experiment one
A dose-response study was carried out to determine whether flutamide (Flubest, BEST Laboratories, México D.F.) suppresses ovulation in laying hens. Hens were assigned to five groups (nZ10-22) and received flutamide orally at doses of 0, 31.25, 62.5. 125 or 250 mg, three times daily at 07 00, 15 00 and 23 00 h. Pills of flutamide were administered orally. The effect of flutamide on ovulation was determined by the occurrence or absence of oviposition 2 days after the beginning of the treatment.
Experiment two
The second experiment determined the effect of the dose of flutamide found in the first experiment to inhibit oviposition on the preovulatory surges of testosterone, oestradiol, progesterone and LH. Nine laying hens (flutamide-treated group) received an oral dose of 250 mg of flutamide every 8 h for 24 h and the control group (nZ10) was fed a placebo. Blood samples were taken from each hen through a teflon 20G!32 mm sterile catheter (Becton Dickinson, Izcalli, Estado de México, Mé xico) inserted into a radial vein. The catheters were kept patent by flushing with 0.5 ml saline solution containing heparin (50 UI/ml, PISA, Guadalajara, Jalisco, Mexico) following the removal of a blood sample. The hens were bled every 2 h for 18 h, starting 4 h before the onset of darkness. In each occasion 2.5 ml of blood was taken, using 3 ml vacutainers containing 45 IU of sodium heparin. After centrifugation plasma was collected and the blood cells were resuspended in 2.5 ml of sterile physiological saline solution with 0.5 mg/ml of gentamicin (Bruluart, Tultitlan, Estado de Mexico, Mexico). The blood cells were stored at 4 8C, and returned to the hens before the next blood sample was taken.
Radioimmunoassays
Testosterone, progesterone and oestradiol were measured by RIA (Coat-a-Count, Diagnostic Products Corporation, Los Angeles, CA, USA). The sensitivities of the assays were 0.04 ng, 0.01 ng and 2.5 pg for testosterone, progesterone and oestradiol respectively. The intra-assay coefficients of variations were 2.5%, 1.2% and 2.6% for the testosterone, progesterone and oestradiol assays respectively. LH was measured as described by Sharp et al. (1987) with a sensitivity of 0.036G0.09 ng/ml and an intra-assay CV of 7.6%. All samples were measured in a single assay for each hormone.
Statistical analyses
The effect of different doses of flutamide on the proportion of hens laying an egg 2 days after treatment was analysed by Fisher's exact test.
A testosterone surge was defined as an increase in testosterone concentrations two standard deviations above the mean concentration of the preceding 4 h. Hormone concentrations data were standardised to the beginning of the testosterone surge (time 0). The surge of progesterone, oestradiol and LH was defined as for testosterone, compared against the mean concentration of time 0 and K2. Data were analysed by analysis of variance for repeated measurements, after logarithmic (natural log of testosterone, progesterone and LH) or square root (oestradiol) transformation of the data to correct for heterogeneity of the variance. Independent variables were the treatment, the hen nested within treatment, time and the interaction between time and treatment. Differences between treatments were analysed using the hen nested within treatment as an error term. Oviposition was evaluated by a Chi-square test, considering as the pretreatment period from 10 days before to 1 day after treatment. The post treatment period corresponds to the second day after treatment. Two out of ten control hens did not ovulate and were excluded from the hormonal analysis.
Results
Experiment one
Flutamide caused a reduction in egg laying at all doses compared with the control group (c 2 Z21.9; P!0.001 (Table 1) ). The treatment with the highest dose of flutamide (250 mg) resulted in the greatest reduction in egg laying and was therefore used for experiment 2.
Experiment two
The rate of egg laying in the 12 day period that preceded treatment was 88% and 86% for control and flutamide groups respectively (PO0.05). Two days after treatment, all nine flutamide-treated hens failed to lay eggs while eight of the ten control hens laid (80%). Changes in concentration of plasma hormones were aligned in relation to the time at which plasma testosterone concentrations began to increase, designated time zero (Fig. 1) . Before this time concentrations of plasma testosterone, progesterone, oestradiol and LH concentrations did not differ (PO0.05) between the flutamide-treated and control groups (Fig. 1) .
The eight control hens that ovulated had simultaneous surges of plasma testosterone, progesterone, oestradiol and LH ( Fig. 1 ; B,C,D) while the two control hens that did not ovulate did not have these surges (data not shown). In the flutamide-treated hens, the testosterone surge occurred in all animals, and it did not differ (PO0.05) from that observed in the eight control hens which ovulated ( Fig. 1; A) . In contrast, progesterone, oestradiol and LH preovulatory surges did not occur in the flutamide-treated hens (Fig. 1B,C,D) . Furthermore, in flutamide-treated hens basal concentrations of progesterone (Fig. 1, B) and oestradiol (Fig. 1, C) did not change with time (PO0.05), whilst LH concentrations were significantly lower after hour 0 (P!0.05) ( Fig. 1; D) .
Discussion
This study demonstrates that in the domestic hen acute blockage of testosterone action during the ovulatory cycle, by the inhibition of its specific receptor with flutamide, blocks egg laying and the associated preovulatory surges of progesterone, oestradiol and LH. It therefore appears that flutamide treatment may block ovulation by preventing the preovulatory surges of progesterone and oestradiol. This conclusion is consistent with the finding that inhibition of testosterone action by passive or active immunisation against testosterone prevents oviposition in laying hens (Furr & Smith 1975 , Rangel et al. 2005 .
Earlier studies suggested that testosterone must first be converted to an "active substance" before it can induce ovulation (Fraps 1955) or act to prime the hypothalamopituitary-ovarian system to facilitate the preovulatory release of LH (Croze & Etches 1980) . The possibility that testosterone must be first converted to an "active substance" to exert a direct stimulatory effect on LH release is unlikely since all evidence points to progesterone being the principal steroid directly inducing the preovulatory release of LH (Wilson & Sharp 1975a , 1976a and progesterone is not a metabolite of testosterone (Norman & Litwack 1997) . The possibility that testosterone primes the hypothalamo-pituitary-ovarian system to facilitate the preovulatory release of LH therefore merits closer analysis. A combination of oestrogen and progesterone treatment primes the hypothalamo-pituitary system of the ovariectomised hen to make it responsive to the stimulatory action of progesterone on LH release (Wilson & Sharp 1976b ). It has not been established whether testosterone might mimic the priming effect of oestrogen. However, it seems unlikely that the preovulatory increase in plasma testosterone is solely responsible for priming the hypothalamo-pituitary system for the stimulatory action of progesterone on LH release since the base-line plasma concentrations of oestrogen in the flutamide-treated hens were not depressed and should have been adequate to exert a priming effect on the hypothalamo-pituitary system (Fig. 1C) . It is therefore possible that the preovulatory peak of testosterone may act to prime the ovary to facilitate the preovulatory release of progesterone.
The principal ovarian source of progesterone for the preovulatory surge is the granulosa cell layer of the mature preovulatory follicle, with subsidiary contributions from the granulosa layer of the next most mature preovulatory follicle (Bahr et al. 1983) . These granulosa cells are targets for testosterone since they contain nuclear androgen receptors (Yoshimura et al. 1993) and when granulosa cells are cultured with testosterone for 48 h basal progesterone production is increased (Phillips et al. 1985) . Sasanami & Mori (1999) confirmed this observation using Japanese quail granulosa cells and further demonstrated that incubation of granulosa cells Testosterone is needed for progesterone and luteinizing hormone release in hens for 66 h with testosterone enhances LH-stimulated progesterone production. This chronic stimulatory action of testosterone contrasts with studies showing that progesterone production from granulosa cells taken from F1 follicles 1.5-3.5 h after ovulation and before they are capable of ovulation is inhibited by treatment with testosterone or oestradiol (Johnson et al. 1988 , Lee & Bahr 1989 , 1990 . This inhibitory effect of testosterone is thought to be part of the mechanism controlling follicular maturation which is characterised by a progressive decrease in androgens and oestrogen in the thecal layer (Bahr et al. 1983) . In non-mature preovulatory follicles these steroids are thought to diffuse from the theca into the granulosa layer to inhibit P450 cholesterol side chain cleavage and 3b hydroxysteroid dehydrogenase to inhibit the synthesis of progesterone (Lee & Bahr 1990) . As a preovulatory follicle matures, concentrations of testosterone and oestrogen in the thecal layer decrease and consequently their inhibitory effects on progesterone synthesis in the granulosa cells decrease, allowing granulosa cell progesterone production to increase in preparation for ovulation. The inhibitory action of testosterone on granulosa cell progesterone production can be reconciled with its stimulatory actions if the response of granulosa cells to testosterone is related to their developmental stage. Granulosa cells from follicles which are capable of ovulation, in contrast to those from follicles which are not capable of ovulation, may respond to testosterone by increasing basal progesterone secretion and responsiveness to the stimulatory action of LH on progesterone production. It therefore seems plausible as suggested by Croze and Etches (1980) that the preovulatory increase in plasma testosterone facilitates the preovulatory release of LH by priming granulosa cells in the maturing preovulatory follicle to increase baseline progesterone secretion and responsiveness to LH. Similarly, in vitro studies with rat granulosa cells also suggest an androgen receptor-mediated stimulation of progesterone production (Hillier et al. 1977) , while Welsh et al. (1982) showed that androgens facilitate progesterone biosynthesis induced by follicle-stimulating hormone (FSH) by enhancing the action of the 3b-HSD enzyme. Furthermore, Schomberg et al. (1978) demonstrated that implants of flutamide in pig ovarian interstitium decreases progesterone secretion by isolated granulosa cells in vitro. These observations show that in mammals testosterone plays a stimulatory role in progesterone production by granulosa cells, and the present findings in the chicken are consistent with this mechanism.
The absence of a preovulatory increase in LH in the flutamide-treated hens may be a consequence of the blockage of a 'priming' effect on of the preovulatory increase in testosterone on the granulosa cells of the largest preovulatory follicle, preventing an increase in responsiveness to the ability of LH to stimulate progesterone production. The absence of an increase in progesterone release would in turn result in the failure of the development of the positive feedback action of progesterone on LH release, and the generation of a preovulatory LH surge. The absence of a preovulatory LH surge may have removed a stimulus for oestrogen production (Robinson & Etches 1986 ) and account for the absence of a preovulatory increase in plasma oestrogen in the flutamide-treated hens.
The increase in plasma testosterone seen in the flutamide-treated hens in the absence of a preovulatory-like release of LH release may be a consequence of the failure of testosterone produced by the thecal cells in the maturing follicle to inhibit progesterone synthesis in the granulosa cells, resulting in an increased substrate for further testosterone synthesis. It is suggested that the initial increase in plasma testosterone preceding a preovulatory release of LH may occur at the developmental stage of the preovulatory follicle when the decreasing testosterone produced by the theca ceases to inhibit granulosa progesterone synthesis resulting in a transitory increase in substrate for granulosa testosterone production. This increase in testosterone production may then 'prime' the granulosa cells making them more responsive to LH to initiate the preovulatory release of LH. A transient increase in plasma testosterone seen before the sustained increase in preovulatory testosterone (Williams & Sharp 1978 ) is consistent with this view.
The progressive decrease in plasma LH seen in the flutamide-treated hens may be a consequence of a stress response that is obscured in hens by the preovulatory increase in plasma LH. This conclusion is consistent with the finding that plasma LH concentrations tend to fall in chickens in which blood samples are removed frequently through indwelling brachial cannulae (Wison & Sharp 1975b ).
To our knowledge, the pharmacology of flutamide in avian species has not been determined. In humans, chronic administration of flutamide can cause liver abnormalities (Chabner et al. 2003) . Nonetheless, we assume that the effects on egg laying and hormone profiles observed in these studies were due to the direct action of flutamide on androgen receptors. The former, is based on the fact that we used an acute treatment limited to the period of time where the final maturation and ovulation of the F1 will occur (Etches 1990) , thus reducing the possible side effects of flutamide on other endocrine or metabolic pathways. Finally, animals resume egg laying a few days after treatment and continue to lay eggs until the end of the laying period, indicating that the liver continues to function normally.
In conclusion, testosterone antagonist (flutamide) blocks ovulation and the preovulatory surges of progesterone, LH and oestradiol in laying hens, demonstrating a key role for testosterone in the ovulatory process in hens.
